PDL-1

Who's going to win pharma's immunotherapy gold rush?
Fierce Biotech
Tue, 03/25/14 - 08:08 am
immunotherapy
Roche
Bristol-Myers Squibb
Merck
PDL-1
anti-PD-1 immunotherapy
melanoma
Inovio CEO Interview: PD1/PDL1 Inhibitors, Immunotherapy And Why Investors Should Be Excited About 2014
Seeking Alpha
Fri, 12/20/13 - 11:49 am
Inovio
Pharma CEOs
PDL-1
immunotherapy
Joseph Kim
Bristol-Myers Squibb
Roche
Dendreon
GSK
ImmunoCellular Therapeutics
Merck
Northwest Biotherapeutics
Cancer immunotherapies turn a corner in race to megablockbuster market
Fierce Biotech
Wed, 10/2/13 - 10:54 am
cancer immunotherapy
Merck
MK-3475
nivolumab
Bristol-Myers Squibb
Roche
MPDL3280A
PDL-1
Bristol-Myers Squibb's Dividend Increase And Promising New Drugs
Seeking Alpha
Tue, 01/29/13 - 10:23 am
dividend
Bristol-Myers Squibb
Eliquis
Yervoy
PDL-1
Abilify
Forixga